Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K221235
    Manufacturer
    Date Cleared
    2022-07-28

    (90 days)

    Product Code
    Regulation Number
    N/A
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K212960, K190160

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Misonix Inc. neXus Ultrasonic System is intended for the fragmentation, emulsification and aspiration of both soft and hard (i.e., bone) tissue.

    The indications for use for the Standard Handpiece in combination with BoneScalpel and SonicOne OR probe kit accessory configurations, the SonaStar®long and short handpieces in combination with SonaStar probe kit accessory configurations, the BoneScalpel AccessTM handpiece with BoneScalpel AccessTM probe kit accessory configurations, and the SonaStar Elite Handpiece with probe kit accessory configurations are listed below.

    Standard Handpiece with BoneScalpel Probe Kits

    Indicated for use in the fragmentation, emulsification of soft and hard (e.g., bone) tissue in the following surgical specialties:

    • · Neurosurgery
    • · Gastrointestinal and Affiliated Organ Surgery
    • · Urological Surgery
    • · Plastic and Reconstructive Surgery
    • · General Surgery
    • · Orthopedic Surgery
    • · Gynecology

    External genitalia - condyloma - benign tumors (lipomas, and leiomyomas) - malignant primary and metastatic tumors of all types and the following cystic lesions: Bartholin's cysts, Vestibular adentis, Inclusion cysts, Sebaceous cysts Abdominal area - any abnormal growth, cystic or solid, benign or malignant, involving the ovary, fallopian tube, uterus, or the supporting structures of the uterus except as contraindicated for uterine fibroids.

    • · Thoracic Surgery
      Limited pulmonary resection such as segmentectomical subsegmentectomies and metastatectornes.

    · Wound Care

    The neXus Ultrasonic Surgical Aspirator is also indicated for use in the debridement of wounds, such as, but not limited to, burn wounds, diabetic ulcers, bedsores and vaginal ulcers, soft tissue debridement and cleansing of the surgical site in applications in which, in the physician's judgment would require the use of an ultrasonic aspirator with sharp debridement.

    Standard Handpiece with SonicOne Probe Kits

    Indicated for use in the fragmentation and aspiration of soft and hard tissue (i.e. bone) in the following surgical specialty:

    · Wound Care

    The neXus Ultrasonic Surgical Aspirator is also indicated for use in the debridement of wounds, such as, but not limited to, burn wounds, diabetic ulcers, bedsores and vaginal ulcers, soft tissue debridement and cleansing of the surgical site in applications in which, in the physician's judgment would require the use of an ultrasonic aspirator with sharp debridement.

    · Plastic and Reconstructive Surgery

    neXus SonaStar Handpieces with SonaStar Probe Kits

    · Indicated for use in the fragmentation, emulsification of both soft and hard (i.e. bone) tissue in the following surgical specialties:
    · Neurosurgery

    · Gastrointestinal and Affiliated Organ Surgery - including removal of benign or malignant tumors or other unwanted tissue, including hepatic parenchyma, in open or laparoscopic procedures, hepatic resection, tumor resection, lobectomy or trisegmentectomy, or removal of tissue during liver allotransplantation and donor hepatectomy

    · Urological Surgery - including removal of renal parenchyma during nephrectomy or partial nephrectomy

    · Plastic and Reconstructive Surgery

    · General Surgery - including removal of benign or malignant tumors or other unwanted tissue in open or minimally invasive general surgical procedures

    • · Orthopedic Surgery
    • · Gynecological Surgery except as contraindicated for uterine fibroids.
    • · Thoracic Surgery

    · Laparoscopic Surgery - including removal of hepatic parenchyma in laparoscopic hepatic resection, lobectomy or trisegmentectomy, in laparoscopic donor hepatectomy or laparoscopic cholecystectomy or laparoscopic pancreatic jejunostomy, or pancreatectomy, or laparoscopic appendectorny, laparoscopic colon resection or laparoscopic partial gastrectomy

    · Thoracoscopic Surgery

    The SonaStar Handpieces may also be combined with electrosurgery using optional RF surgery interface components.

    Bone Scalpel Access Handpiece with BoneScalpel Access Probe Kits

    Indicated for use in the fragmentation of soft and hard (e.g.: bone) tissue in the following surgical specialties:

    • · Neurosurgery
    • · Gastrointestinal and Affiliated Organ Surgery
    • · Urological Surgery
    • · Plastic and Reconstructive Surgery
    • · General Surgery
    • · Orthopedic Surgery
    • · Gynecology

    External genitalia - condyloma - benign tumors (lipomas, and leiomyomas) - malignant primary and metastatic tumors of all types and the following cystic lesions: Bartholin's cysts, Vestibular adentis, Inclusion cysts, Sebaceous cysts Abdominal area - any abnormal growth, cystic or solid, benign or malignant, involving the ovary, fallopian tube, uterus, or the supporting structures of the uterus except as contraindicated for uterine fibroids.

    • · Thoracic Surgery
      Limited pulmonary resection such as segmentectomical subsegmentectomies and metastatectomies.

    SonaStar Elite Handpiece with SonaStar Elite Probe Kits

    Indicated for use in the fragmentation of soft and hard (e.g., bone) tissue in the following surgical specialties:

    • · Neurosurgery
      • Gastrointestinal and Affiliated Organ Surgery – including removal of benign or malignant tumors or other unwanted tissue, including hepatic parenchyma, in open or laparoscopic procedures, hepatic resection, tumor resection, lobectomy or trisegmentectomy, or removal of tissue during liver allotransplantation and donor hepatectomy

    • · Urological Surgery including removal of renal parenchyma during nephrectomy or partial nephrectomy

    • · Plastic and Reconstructive Surgery

    • · General Surgery including removal of benign or malignant tumors or other unwanted tissue in open or minimally invasive general surgical procedures

    • · Orthopedic Surgery

    • · Gynecological Surgery except as contraindicated for uterine fibroids.

    • · Thoracic Surgery

    · Laparoscopic Surgery - including removal of hepatic parenchyma in laparoscopic hepatic resection, lobectomy or trisegmentectomy, in laparoscopic donor hepatectomy or laparoscopic cholecystectomy or laparoscopic pancreatic jejunostomy, or pancreatectomy, or laparoscopic appendectorny, laparoscopic colon resection or laparoscopic partial
    · Thoracoscopic Surgery

    The system may also be combined with electrosurgery using optional RF surgery interface components.

    Device Description

    The neXus Ultrasonic Surgical Aspirator System is intended for fragmentation, emulsification and aspiration of both soft and hard (i.e., bone) tissue. The system includes a generator housed inside the console. A reusable handpiece is plugged directly into the front panel of the console.

    The generator and handpiece are compatible with various single use disposable "probes" which are selected and attached to the handpiece by the end user. An irrigation unit provides sterile irrigant to the operative site. An aspiration system removes the fragmented, emulsified material and waste liquids from the operative site.

    Accessories include a wireless footswitch, various probe tip combinations, sterilization trays, probe covers, assembly & disassembly wrenches, irrigation tubing sets, and waste collection canisters.

    AI/ML Overview

    The provided text is a 510(k) Premarket Notification from the FDA for a medical device. It focuses on demonstrating substantial equivalence to a predicate device rather than presenting a study to prove the device meets specific acceptance criteria for a novel AI/software component.

    Therefore, the document does not contain the information requested in your prompt regarding acceptance criteria and a study proving a device meets these criteria, especially concerning AI/software performance metrics like sensitivity, specificity, or reader improvement with AI assistance.

    The document primarily focuses on:

    • Device Description and Intended Use: Detailing the neXus Ultrasonic Surgical Aspirator System and its various configurations for fragmentation, emulsification, and aspiration of soft and hard tissue in different surgical specialties.
    • Technological Comparison: Comparing the subject device's features (Compatible Handpieces, Principle of Operation, Reusable/Disposable Accessories, Cleaning & Sterilization, Electrosurgery, Console features, etc.) to a predicate device (CUSA Clarity Ultrasonic Aspirator System, K200774).
    • Performance Data: Presenting evidence for biocompatibility, sterility/shelf life, electrical safety, electromagnetic compatibility (EMC), and software verification/validation.
      • Biocompatibility: Mentions testing against ISO 10993 standards (Cytotoxicity, Sensitization, Irritation/Intracutaneous Reactivity, Acute Systemic Toxicity, Pyrogenicity).
      • Sterility and Shelf Life: Describes testing for single-use and reusable components and accelerated/real-time aging studies for shelf life.
      • Electrical Safety and EMC: Confirms testing to IEC 60601 standards.
      • Software Verification and Validation: States that V&V testing was conducted as per FDA guidance for "major" level of concern software.
      • Bench Testing: Lists tests performed, including Acoustic Intensity, Applied Part Temperature, Probe Vibration, Soft Tissue Performance, and Probe Life Testing.
    • Absence of Animal or Clinical Data: Explicitly states that animal and clinical studies were "Not applicable" as they were "not necessary to establish the substantial equivalence of this device."

    In summary, this document is a regulatory submission for substantial equivalence based on technological and performance similarities to an existing device, not a performance study for a new AI/software feature with defined acceptance criteria and clinical outcome measures.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1